Identification of amino acid residues crucial for chemokine receptor dimerization

Nature Immunology

Volumn 5, Issue 2, 2004, Pages 216-223

  Hernanz Falcón, Patricia ^a   Rodríguez Frade, José Miguel ^a   Serrano, Antonio ^a   Juan, David ^a   del Sol, Antonio ^a   Soriano, Silvia F ^a   Roncal, Fernando ^a   Gómez, Lucio ^a   Valencia, Alfonso ^a   Martínez A, Carlos ^a   Mellado, Mario ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; ISOLEUCINE; LIGAND; OLIGOMER; SYNTHETIC PEPTIDE; VALINE;

ARTICLE; BIOINFORMATICS; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR STABILITY; MUTATION; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AMINO ACIDS; ANIMALS; CALCIUM SIGNALING; CELL LINE; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIGANDS; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; OLIGOPEPTIDES; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, CCR5; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 10744223537     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1027     Document Type: Article

References (54)

1. Mackay, C.R. Chemokines: immunology's high impact factors. Nat. Immunol. 2, 95-101 (2001).
2. Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242 (2000).
3. Mellado, M., Rodríguez-Frade, J.M., Mañes, S. & Martínez-A., C. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Ann. Rev. Immunol. 19, 397-421 (2001).
4. Angers, S., Salahpour, A. & Bouvier, M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435 (2002).
5. Hebert, T.E. et al. A peptide derived from a β2-adrenergic receptor transmembrane inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392(1996).
6. Zeng, F.Y. & Wess, J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274, 19487-19497 (1999).
7. B-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683-687 (1998).
8. Galvez, T. et al. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J. 20, 2152-2159 (2001).
9. Milligan, G. Oligomerization of G-protein-coupled receptors. J. Cell Sci. 114, 1265-1271 (2002).
10. Tsuji Y. et al. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 275, 28144-28151 (2000).
11. B receptor. Nature 396, 679-682 (1998).
12. Filizola, M. & Weinstein, H. Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. Biopolymers 66, 317-325 (2002).
13. Benkirane, M., Jin, D.Y., Chun, R.F., Koup, R.A. & Jeang, K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. J. Biol. Chem. 272, 30603-30606 (1997).
14. Issafras, H. et al. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J. Biol. Chem. 277, 34666-34673 (2002).
15. Babcock, G.J., Farzan, M. & Sodroski, J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. 278, 3378-3385 (2003).
16. Blanpain, C. et al. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol. Biol. Cell 13, 723-737 (2002).
17. Rodríguez-Frade, J.M., Mellado, M. & Martínez-A., C. Chemokine receptor dimerization: two are better than one. Trends Immunol. 22, 612-617 (2001).
18. Mellado, M. et al. Chemokine receptor homo- or hetero-dimerization activates distinct signaling pathways. EMBO J. 20, 2497-2507 (2001).
19. Vila-Coro, A.J. et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. USA 97, 3388-3393 (2000).
20. Gobel, U., Sander, C., Schneider, R. & Valencia, A. Correlated mutations and residue contacts in proteins. Proteins 18, 309-317 (1994).
21. Pazos, F. & Valencia, A. In silico two-hybrid system for the selection of physically interacting protein pairs. Proteins 47, 219-227 (2002).
22. Casari, G., Sander, C. & Valencia, A. A method to predict functional residues in proteins. Nat. Struct. Biol. 2, 171-178 (1995).
23. del Sol Mesa, A., Pazos, F. & Valencia, A. Automatic methods for predicting functionally important residues. J. Mol. Biol. 326, 1289-1302 (2003)
24. Manes, S. et al. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 18, 6211-6220 (1999).
25. Harder, T., Scheiffele, P., Verkade, P. & Simons, K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929-942 (1998).
26. Kenworthy, A.K. Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24, 289-296 (2001).
27. Gordon, G.W., Berry, G., Liang, X.H., Levine, B. & Herman, B. Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys. J. 74, 2702-2713 (1998).
28. Bastiaens, P.I. & Squire, A. Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. Trends Cell Biol. 9, 48-52 (1999).
29. Angers, S. et al. Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) Proc. Natl. Acad. Sci. USA 97, 3684-3689 (2000).
30. Desai, D.M., Newton, M.E., Kadlecek, T. & Weiss A. Stimulation of the phosphatidylinositol pathway can induce T-cell activation. Nature 348, 66-69 (1990).
31. Klemm, J.D., Schreiber, S.L. & Crabtree, G.R. Dimerization as a regulatory mechanism in signal transduction. Annu. Rev. Immunol. 16, 569-592 (1998).
32. Devi, L. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharm. Sci. 22, 532-537 (2001).
33. Gether, U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrinol. Rev. 21, 90-113 (2000).
34. Ghanouni, P., Steenhuis, J.J., Farrens, D.L. & Kobilka, B.K. Agonist-induced conformational changes in the G protein-coupling domain of the β2 adrenergic receptor. Proc. Natl. Acad. Sci. USA 98, 5997-6002 (2001).
35. Ri, Y. et al. The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys J. 76, 2887-2889 (1999).
36. Govaerts, C. et al. The TXP motif in the second transmembrane helix of CCR5. J. Biol. Chem. 276, 13217-13225 (2001).
37. Soriano, S.F. et al, Chemokines integrate JAK/STAT and G protein pathways during chemotaxis and calcium flux responses. Eur. J. Immunol. 33, 1328-1333 (2003).
38. Onuffer, J.J. & Horuk R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharm. Sci. 23, 459-467 (2002).
39. Tarasova, N. I., Rice, W. G. & Michejda, C.J. Inhibition of G-protein-coupled receptor function by disruption transmembrane domain interactions. J. Biol. Chem. 274, 34911-34915 (1999).
40. Dragic, T. et al. A binding pocket for small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 97, 5639-5644 (2000).
41. Mirzadegan, T et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists. J. Biol. Chem. 275, 25562-25571 (2000)
42. Horn, F. et al. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res. 31, 294-297 (2003).
43. Notredame, C., Higgins, D.G. & Heringa, J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205-217 (2000).
44. Filizola, M., Olmea, O. & Weinstein, H. Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. Protein Eng. 15, 881-885 (2002).
45. Palczewski, K, et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745 (2000).
46. Katchalski-Katzir, E. et al. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. USA 89, 2195-2199 (1992).
47. Vakser, I.A. & Jiang, S. Strategies for modeling the interactions of transmembrane helices of G protein-coupled receptors by geometric complementarity using the GRAMM computer algorithm. Methods Enzymol. 343, 313-328 (2002).
48. Pazos, F., Helmer-Citterich, M., Ausiello, G. & Valencia, A. Correlated mutations contain information about protein-protein interaction. J. Mol. Biol. 271, 511-523 (1997).
49. Gong, X. et al. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J. Biol. Chem. 272, 11682-11685 (1997).
50. Mellado, M. et al. The chemokine MCP-1 triggers tyrosine phosphorylation of the CCR2B receptor and the JAK2/STAT3 pathway. J. Immunol. 161, 805-813 (1998).
51. Gausepohl, H. et al. Automated multiple peptide synthesis. Peptide Res. 5, 315-320 (1992).
52. Sorkin, A., McClure, M., Huang, F. & Carter, R. Interaction of EGF receptor and grb2 in living cells visualized by fluorescence visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr. Biol. 10, 1395-1398 (2000).
53. Gu, C., Cali, J.J. & Cooper, D.M. Dimerization of mammalian adenylate cyclases. Eur. J. Biochem. 269, 413-421 (2002).
54. Xia, Z. & Liu, Y. Reliable and global measurement of fluorescence resonance energy transfer using fluorescence resonance energy transfer (FRET) microscopy. Biophys. J. 81, 2395-4028 (2001).